Dexcom, Inc. (DXCM) · page 21 of 83
The slide contrasts the 'bull' narrative (Dexcom is superior for high-need patients) with the author's counter-argument (Libre 2 will level the playing field).
Activist deck · comparison_table · compare_peers · balanced density
Slide locked Sign in to view
Slide schematic 4/4
callout 1/1 paragraph 1/1 table 1/1 title 1/1
Components 4
primary paragraph data headline
Tools 0
∅
No tools
No canon tool match is anchored to this slide.
Metrics 0
∅
No metrics
No metric insight is anchored to this slide.
Frameworks 1